key: cord-0915080-v64zstf8 authors: Bagheri, Seyed Morteza; Tabrizi, Zhale title: Deep dorsal penile vein thrombosis in a patient with COVID‐19 infection: A rare complication and the first reported case date: 2021-12-06 journal: Clin Case Rep DOI: 10.1002/ccr3.5117 sha: 1878cf3a7b4a4e213d03498ef29e00b15758551f doc_id: 915080 cord_uid: v64zstf8 COVID‐19 infection may have extrapulmunary manifestations such as blood hypercoagulability that may cause thrombosis in both arterial and venous system. Deep dorsal penile vein thrombosis is very rare, and the most common reason is coagulation disorders. The common observed symptom is penile pain especially during erection and it is diagnosed by ultrasound evaluation of the vein. It is necessary to distinguish deep dorsal penile vein thrombosis from superficial dorsal penile vein thrombosis as it needs anti‐coagulant treatment. In present study, we describe a unique case of the deep dorsal penile vein thrombosis following COVID‐19 infection. Venous thrombosis of the penis is often related to thrombosis of the superficial veins (Mondor disease), that has been well reported in the literature in the last decades. 1 While Thrombosis of the deep dorsal penile vein has been rarely reported. 2 These two conditions need different treatments, for instance, mondor disease can be cured simply through or after treating by anti-inflammatory or anti-coagulant drugs. But thrombosis of the deep veins may cause serious complications such as ischemia and priapism, therefore it needs to be treated by anticoagulants. To this end, It is important to distinguish the two conditions from another. 3, 4 Although COVID-19 is mostly known for its respiratory symptoms, it can also have many extrapulmonary manifestations, such as thrombotic complications, mostly pulmonary embolism and deep venous thrombosis. 5, 6 In the present study, a unique case of deep dorsal penile vein thrombosis following COVID-19 infection is reported for the first time. The case study is devoted to investigating of penile pain in a 41-year-old married man. According to medical evaluation, the pain extended to the perineal and inguinal regions and it was reported to be more acute during erection. The patient was referred by urologist for sonographic evaluation of penis and testes. The pain had started 3 days before the urologist examination, following his first full erection for intercourse, after his positive COVID-19 polymerase chain reaction (PCR) test. The patient did not have any other urologic symptoms such as discharge, hematuria, or dysuria. He denied any trauma to the penis, previous pelvic tumor, pelvic surgery and history of recent immobilization. He did not use vasoconstrictive drugs. The patient reported positive nosopharyngeal swab test for COVID-19 three weeks earlier. He had mild symptoms of COVID-19 infection including muscle pain, fever, cough, and fatigue. He had received conservative treatment and had not taken any anticoagulants, antivirals, and corticosteroids. His medical history did not show any significant underlying disease and any risk factor for cardiovascular disease. He also did not have history of previous deep vein thrombosis. In physical examination of the penis and testes, no pathologic finding was detected such as skin tissue changes, discoloration, edema, tenderness, or palpable nodularity. Ultrasound evaluation showed thrombosis of deep dorsal penile vein while the superficial dorsal penile vein, iliac veins, and inferior vena cava were intact (Figures 1,2,3) . Laboratory tests revealed slightly increased D-dimer level(may be due to inflammatory process of COCID-19 infection), normal levels of fibrinogen, anti-thrombin III, protein S, Protein C, anti-cardiolipin antibodies and normal count of platelets and white blood cell counts. Also Tests were negative for anti-phospholipid-IgG, IgM, and lupus anti-coagulant (Table 1) . Immediately after sonographic diagnose of deep dorsal penile vein thrombosis, the Rivaroxaban treatment was started with the dosage of 15 mg twice a day. Two months after starting the treatment, patient's symptoms were completely disappeared and he had no penile pain during erection and sexual disturbances anymore. Ultrasound evaluation revealed no evidence of acute deep dorsal penile vein thrombosis. Old partial thrombosis at The coronavirus is mostly known to cause pulmonary disease such as pneumonia or acute respiratory distress syndrome; however, during the course of COVID-19 pandemic, it exhibits some extrapulmunary manifestations including hematologic, neurologic, cardiovascular, gastrointestinal and renal manifestations. [7] [8] [9] [10] [11] This pathology may be due to extracellular proliferation of the COVID-19 virus and the induction of immunopathological reactions, as it has been reported previously for other zoonotic coronaviruses in the literature. 12 Coagulopathy as a part of the systemic inflammatory response syndrome is a prevalent feature of COVID-19 infection. Roughly, 20%-50% of hospitalized patients with COVID-19 infection have abnormal coagulation tests (elevated D-dimer, prolonged prothrombin time, prolonged clotting time, thrombocytopenia and low fibrinogen levels) which can cause thrombosis and microvascular occlusion, due to endothelial dysfunction, cytokine storm, hypoxia, and immobilization. [13] [14] [15] [16] [17] [18] [19] Increased D-dimer leads to consumption of natural coagulation inhibitors that can cause vascular thrombosis. 20 Venous drainage of the penis is performed through the following pathways: (1) The superficial dorsal venous system, which is responsible for draining the skin and soft subcutaneous tissue. The superficial dorsal venous system eventually drained in to the external pudendal vein that is anatomically linked to the long saphenous vein at the groin and (2) The deep dorsal venous system, which is responsible for draining of the glans, corpus spongiosum and the distal two thirds of corpora cavernosa. The deep dorsal venous system eventually drained in to the prostatic and perivesical venous system. 4, 21 The pathogenesis of thrombophlebitis is the wellknown Virchow triad which was introduced in 1845: (1) Endothelial vascular wall damage, (2) venous stasis and (3) changes in blood components. 22 The cause of thrombosis in the penis is mostly thrombosis of superficial venous system, which is known as Mondor disease. But deep vein thrombosis has been reported very rarely in the literature. 4 The etiology of Mondor disease is unknown, but some etiologies listed below are reported in the previous studies: sexual activity, infection, penis injection, direct trauma, cancer, and a deficit of anti-thrombin III, Protein C and S and previous surgical hernia repair. 3 Patients with Mondor disease are usually asymptomatic but some of them may have penile pain, erythema of the penis or palpable superficial thrombosed vein. Generally, Mondor disease is self limiting and just need conservative treatments, and in most cases it will not have any complications. 2 As mentioned before, deep dorsal penile vein thrombosis is very rare compared to the superficial vein thrombosis and the most common cause of spontaneous dorsal deep vein thrombosis is coagulation disorders without inflammatory processes. Since this vein is a part of deep venous system, thrombosis of deep dorsal penile vein can increase the risk of pulmonary embolism leading to significant increase in mortality and morbidity. 23, 24 So investigation for other sites of thrombosis and starting appropriate treatment is necessary. 24, 25 Searching the literature showed no previously published similar case of deep dorsal penile vein thrombosis fallowing COVID-19 infection and our patient is the first reported case. Only superficial dorsal penile vein thrombosis are reported previously. 19 COVID-19 infection can cause coagulopathy due to cytokine release and immunopathological reactions. In some hospitalized patient it can cause pulmonary embolism or deep vein thrombosis, but in non-hospitalized patients can cause small deep vein thrombosis. So it is important for clinicians to investigate the risk of thrombosis in COVID-19 patients especially those with risk factors or previous deep venous thrombosis. It is necessary to do further studies and realize if it is necessary to add prophylactic anti-coagulant to treatment regimen of COVID-19 patients who are not hospitalized or not. None. The Authors declare that there are no competing interests. All ethics standards and consent were obtained for this manuscript. Written informed consent for publication was obtained from the patient. Data sharing not applicable-no new data generated. Data sharing is not applicable to this article as no new data were created or analyzed in this study. Zhale Tabrizi https://orcid.org/0000-0002-4961-1713 F I G U R E 6 Two months after starting the treatment. There is no evidence of thrombosis at the deep dorsal penile vein except the proximal part of the vein showed in Figures 4,5 . The vein is seen with normal diameter and velocity Penile Mondor's disease in a 22-year-old man Elevated plasma factor VIII coagulant activity presenting with thrombophlebitis of the deep dorsal vein of the penis Subcutaneous penile vein thrombosis (Penile Mondor's disease): pathogenesis, diagnosis, and therapy Deep vein thrombosis of the penis: an unusual but severe complication of prostatic abscess Extrapulmonary manifestations of COVID-19 SARS-CoV-2 infection as a determining factor to the precipitation of ischemic priapism in a young patient with asymptomatic COVID-19 Clinical characteristics of coronavirus disease 2019 in China Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study A pneumonia outbreak associated with a new coronavirus of probable bat origin Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China Association of cardiac injury with mortality in hospitalized patients With COVID-19 in Wuhan, China SARS coronavirus: a new challenge for prevention and therapy ISTH interim guidance on recognition and management of coagulopathy in COVID-19: a comment Thromboinflammation and the hypercoagulability of COVID-19 Blood transfusion utilization in hospitalized COVID-19 patients Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): a case series Coagulopathy associated with COVID-19 Penile Mondor's in a Covid-19 patient on prophylactic anti-thrombosis with rivaroxaban: a case report Coagulation abnormalities and thrombosis in patients with COVID-19 Traumatic thrombophlebitis of the superficial dorsal vein of the penis: an occupational hazard Pathogenesis of venous thrombosis Spontaneous thrombosis of the deep dorsal penile vein in a patient with thrombophilia Comparison of a clinical probability estimate and two clinical models in patients with suspected pulmonary embolism Prevention of thrombotic disorders in cancer patients undergoing chemotherapy